Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04160910 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

5HTP Regulation Of Asthma In Children

StatusRecruiting
PhasePhase 2
Started2021-02-11
View on ClinicalTrials.gov ↗

Amendment history

2026-02-26
Study Status v7
Primary completion date2026-01-05→2026-06-30
Completion date2026-01-05→2026-06-30
2025-10-03
Study Status v6
Primary completion date2025-08-16→2026-01-05
Completion date2025-08-16→2026-01-05
2025-03-28
Study Status v5
Primary completion date2024-12→2025-08-16
Completion date2024-12→2025-08-16
2024-02-26
Study Status v4
Primary completion date2023-12→2024-12
Completion date2023-12→2024-12
2023-05-17
Study Status v3
Completion date2024-12→2023-12
Show 2 earlier versions
2023-03-01
Study Status, Eligibility v2
Primary completion date2022-09→2023-12
Completion date2023-09→2024-12
Start date2019-09-12→2021-02-11
Eligibility criteriarevised
Inclusion Criteria: Age 8-1718 Years of Age Mild to Moderate Asthma based on ATS guideline [...]
2022-01-20
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusActive, Not Recruiting→Recruiting
Primary completion date2020-09→2022-09
Completion date2021-09→2023-09
Study sitesdetails revised at 1 of 1 site
2019-11-08
Original filing
Indiana University
306 trials monitored
See 37 trials at risk
Asthma
918 trials monitored
See 28 trials at risk
The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.
Trial Details
NCT Number NCT04160910
Lead Sponsor Indiana University
Conditions Mild or Moderate Asthma With Allergic Sensitization
Enrollment 20 participants
Start Date 2021-02-11
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-10-01